Why the study?
Advances in medical optimization and LVAD therapy have shown potential for reverse remodeling and myocardial recovery sufficient for device explant, prompting a review of optimization, assessment, explant methodologies, and post-recovery outcomes.
LVAD therapy combined with guideline-directed medical therapy can promote myocardial reverse remodeling and recovery, potentially allowing for successful device explantation.
Answers are grounded in this paper and cite their sources.
Supports LVAD recovery protocols in select patients; leaves open prospective trials for selection and durability.
The management of chronic heart failure over the past decade has witnessed tremendous strides in medical optimization and device therapy including the use of left ventricular assist devices (LVAD). What we once thought of as irreversible damage to the myocardium is now demonstrating signs of reverse remodeling and recovery. Myocardial recovery on the structural, molecular, and hemodynamic level is necessary for sufficient recovery to withstand explant and achieve sustained recovery post-LVAD. Guideline-directed medical therapy and unloading have been shown to aid in recovery with the potential to successfully explant the LVAD. This review will summarize medical optimization, assessment for recovery, explant methodologies and outcomes post-recovery with explant of durable LVAD.
No takes yet. Share an insight, caveat, or question.
Hamad et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: